Rune Rasmussen, M.Sc.

Affiliations: 
Yonehara Group DANDRITE/Nordic EMBL/Aarhus University 
Area:
Neuroscience
Website:
https://www.researchgate.net/profile/Rune_Rasmussen5
Google:
"Rune Rasmussen"
Mean distance: 18.43 (cluster 22)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rasmussen R, Nicholas E, Petersen NC, et al. (2019) Cortex-wide Changes in Extracellular Potassium Ions Parallel Brain State Transitions in Awake Behaving Mice. Cell Reports. 28: 1182-1194.e4
Rasmussen RD, Gajjar MK, Tuckova L, et al. (2018) Author Correction: BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity. Nature Communications. 9: 5396
Staberg M, Rasmussen RD, Michaelsen SR, et al. (2018) Targeting glioma stem-like cell survival and chemo-resistance through inhibition of lysine-specific histone demethylase KDM2B. Molecular Oncology
Rasmussen R, Yonehara K. (2017) Circuit Mechanisms Governing Local vs. Global Motion Processing in Mouse Visual Cortex. Frontiers in Neural Circuits. 11: 109
Kjaerby C, Rasmussen R, Andersen M, et al. (2017) Does Global Astrocytic Calcium Signaling Participate in Awake Brain State Transitions and Neuronal Circuit Function? Neurochemical Research
Rasmussen RD, Gajjar MK, Tuckova L, et al. (2016) BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity. Nature Communications. 7: 13398
Staberg M, Michaelsen SR, Rasmussen RD, et al. (2016) Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine. Cellular Oncology (Dordrecht)
Rasmussen R, Nedergaard M, Petersen NC. (2016) Sulforhodamine 101, a widely used astrocyte marker, can induce cortical seizure-like activity at concentrations commonly used. Scientific Reports. 6: 30433
Rasmussen RD, Gajjar MK, Jensen KE, et al. (2016) Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma. Molecular Oncology
Venere M, Hamerlik P, Wu Q, et al. (2014) Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells. Cell Death and Differentiation. 21: 258-69
See more...